FDA Determines Regulatory Review Period for YERVOY Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for YERVOY, a human biological product, in accordance with federal regulations, following a request from the patent holder to extend the patent's validity period.